Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2021-04-19 08:01Moberg Pharma Annual Report for July 2019 - December 2020Read more 2021-04-19 08:00Notice of Annual General Meeting in Moberg Pharma AB (publ)Read more 2021-02-10 14:30OncoZenge has been approved for listing on Nasdaq First North Growth MarketRead more 2021-02-09 08:00Moberg Pharmas Year-end report 2020Read more 2021-02-08 16:00Correction regarding ISIN code for the share in the prospectusRead more 2021-02-08 11:00OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectusRead more Pagination First page Previous page … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2020-04-28 18:00Bulletin from Moberg Pharma's Extraordinary General Meeting on April 28[th], 2020Read more 2020-03-27 08:30Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)Read more 2020-03-23 21:00Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015Read more 2020-02-11 08:00Moberg Pharma AB Interim report October - December 2019Read more 2020-02-04 08:00Moberg Pharma's Interim report to be published on February 11 - Invitation to teleconferenceRead more 2020-01-22 08:00Expert evaluation clarifies Phase 3 results and provides strong support for MOB-015Read more Pagination First page Previous page … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 … Next page Last page
